Clinical Trial Update: A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing the effect of activated charcoal on absorption of LY2216684 in healthy subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Activated Charcoal (activated charcoal)
• LY2216684

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED | Results posted: 2018-10-19